CNET [ChinaNet Online] 8-K: (Original Filing)

[ChinaNet Online Holdings, Inc. Reports First Quarter 2010 Financial Results Beijing, China, May 17, 2010 § First quarter 2010 adjusted net income § Company launches new growth initiatives § Company reaffirmed 2010 revenue guidance of $45.0 million and adjusted net income guidance of $14.1 million, representing 19.0% and 67.9% growth over 2009 revenue and adjusted net income, respectively § Management]

By | 2016-03-05T02:01:31+00:00 May 18th, 2010|Categories: Chinese Stocks, CNET, SEC Original|Tags: , , , , , |0 Comments

CNET [ChinaNet Online] 8-K: ChinaNet Online Holdings, Inc. Reports First Quarter 2010

[ChinaNet Online Holdings, Inc. Reports First Quarter 2010 Financial Results Beijing, China, May 17, 2010 § First quarter 2010 adjusted net income § Company launches new growth initiatives § Company reaffirmed 2010 revenue guidance of $45.0 million and adjusted net income guidance of $14.1 million, representing 19.0% and 67.9% growth over 2009 revenue and adjusted net income, respectively § Management]

By | 2016-03-05T02:02:39+00:00 May 18th, 2010|Categories: Chinese Stocks, CNET, Webplus ver|Tags: , , , , , |0 Comments

CNET [ChinaNet Onlines,] 8-K: ChinaNet Onlines, Reports First Quarter 2010 Financial Results

[ChinaNet Onlines, Reports First Quarter 2010 Financial Results Beijing, China, May 17, 2010 First quarter 2010justed netomempany launches new growth initiativesmpany reaffirmed 2010 revenue guidance of $45.0 million andjusted netome guidance of $14.1 million, representing 19.0% and 67.9% growth over 2009 revenue andjusted netome, respectively]

By | 2016-02-08T13:17:23+00:00 May 18th, 2010|Categories: Chinese Stocks, CNET, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[NEWS RELEASE Skystar Bio-Pharmaceutical Reports 27% Growth in Revenue From Continuing Operations in First Quarter Fiscal Year 2010 Gross Margin of 53%; $0.15 Diluted Earnings Per Share; Fiscal 2010 Top Line Guidance Increased to $45.5 Million to $47.5 Million XI’AN, CHINA – May 18, 2010 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), First Quarter 2009 Highligh ts]

By | 2016-03-01T06:07:27+00:00 May 18th, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: NEWS RELEASE Skystar Bio-Pharmaceutical Reports 27% Growth in

[NEWS RELEASE Skystar Bio-Pharmaceutical Reports 27% Growth in Revenue From Continuing Operations in First Quarter Fiscal Year 2010 Gross Margin of 53%; $0.15 Diluted Earnings Per Share; Fiscal 2010 Top Line Guidance Increased to $45.5 Million to $47.5 Million XI’AN, CHINA – May 18, 2010 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), First Quarter 2009 Highligh ts]

By | 2016-03-01T06:08:15+00:00 May 18th, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

CNET [ChinaNet Onlines,] 8-K: (Original Filing)

[ChinaNet Onlines, Reports First Quarter 2010 Financial Results Beijing, China, May 17, 2010 First quarter 2010justed netomempany launches new growth initiativesmpany reaffirmed 2010 revenue guidance of $45.0 million andjusted netome guidance of $14.1 million, representing 19.0% and 67.9% growth over 2009 revenue andjusted netome, respectively]

By | 2016-02-08T13:16:51+00:00 May 18th, 2010|Categories: Chinese Stocks, CNET, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar